Effectiveness of Fractionated Rituximab in Preventing Tumor
Lysis Syndrome in Aggressive B-Cell Lymphoma: Insights from Real-Life
Clinical Practice
Jasmine Mohamad1, Antonin
Bouroumeau2, Thomas A. McKee2,
Nicolas Mach3, Kaveh Samii4, Martine
Chamuleau5, Frank Stenner6, Jerome
Tamburini1,2, Noémie Lang1,2
1University of Geneva, Geneva, Switzerland
2Department of Patho-Immunology, Geneva University
Medical Centre, Switzerland
3Department of Oncology, Hôpitaux Universitaires de
Genève, Geneva, Switzerland
4Department of Hematology, Hôpitaux Universitaires de
Genève, Geneva, Switzerland
5Department Hematology, Cancer Center Amsterdam,
Amsterdam UMC, location VU, Amsterdam, Netherlands
6Department Oncology, University Hospital Basel and
SAKK, Basel, Switzerland